BTG1 Gene - B-Cell Translocation Gene 1: Function, Mutations, and Disease Associations

BTG1 (B-cell translocation gene 1) is a protein-coding gene that functions as a tumor suppressor. It is a member of the BTG/Tob family of anti-proliferative genes. BTG1 regulates cell cycle progression, differentiation, and apoptosis. It is frequently involved in chromosomal translocations in B-cell malignancies, particularly in acute lymphoblastic leukemia (ALL) and mantle cell lymphoma. The gene encodes a protein that interacts with transcription factors and chromatin remodeling complexes to modulate gene expression.

Disease category	Pathophysiological mechanism	Genomic evidence
Acute lymphoblastic leukemia (ALL)	Chromosomal translocation t(8;12)(q24;q22) involving BTG1 and MYC leads to dysregulation of cell proliferation.	COSMIC, ClinVar
Mantle cell lymphoma	BTG1 deletions and mutations contribute to disease pathogenesis by impairing cell cycle control.	COSMIC, ClinVar
Diffuse large B-cell lymphoma	Somatic mutations in BTG1 are recurrent and associated with poor prognosis.	COSMIC, ClinVar

The BTG1 protein is a 171-amino acid anti-proliferative factor. It contains a conserved N-terminal domain (BTG domain) that mediates protein-protein interactions. BTG1 localizes to the nucleus and acts as a transcriptional corepressor. It regulates cell cycle progression by inhibiting cyclin D1 expression and promoting p21 expression. BTG1 also interacts with the CCR4-NOT complex to modulate mRNA stability. Post-translational modifications include phosphorylation and ubiquitination, which regulate its stability and function.